The Impact of Chronic Hepatitis C Virus Infection on Mortality

被引:8
作者
Nelson, Kenrad E. [1 ]
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
LONG-TERM MORTALITY; GENERAL-POPULATION; RISK-FACTORS; DRUG-USERS; NON-A; NON-B; COHORT; SEROPOSITIVITY; ASSOCIATION; ATHEROSCLEROSIS;
D O I
10.1093/infdis/jis394
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:461 / 463
页数:3
相关论文
共 50 条
  • [31] Polymorphisms of some cytokines and chronic hepatitis B and C virus infection
    Gao, Qiu-Ju
    Liu, Dian-Wu
    Zhang, Shi-Yong
    Jia, Min
    Wang, Li-Min
    Wu, Li-Hong
    Wang, Shu-Yun
    Tong, Li-Xin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (44) : 5610 - 5619
  • [32] HLA Class II Alleles and Chronic Hepatitis C Virus Infection
    Cangussu, L. O. F.
    Teixeira, R.
    Campos, E. F.
    Rampim, G. F.
    Mingoti, S. A.
    Martins-Filho, O. A.
    Gerbase-DeLima, M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 74 (03) : 282 - 287
  • [33] Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection
    Soderholm, Jonas
    Waldenstrom, Jesper
    Askarieh, Galia
    Pilli, Massimo
    Bochud, Pierre-Yves
    Negro, Francesco
    Pawlotsky, Jean-Michel
    Zeuzem, Stefan
    Ferrari, Carlo
    Norkrans, Gunnar
    Wejstal, Rune
    Westin, Johan
    Neumann, Avidan U.
    Haagmans, Bart L.
    Lindh, Magnus
    Missale, Gabriele
    Hellstrand, Kristoffer
    Lagging, Martin
    PLOS ONE, 2013, 8 (02):
  • [34] Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis
    Deng, Li-Ping
    Gui, Xi-En
    Zhang, Yong-Xi
    Gao, Shi-Cheng
    Yang, Rong-Rong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (08) : 996 - 1003
  • [35] Burden of disease and cost of chronic hepatitis C virus infection in Canada
    Myers, Robert P.
    Krajden, Mel
    Bilodeau, Marc
    Kaita, Kelly
    Marotta, Paul
    Peltekian, Kevork
    Ramji, Alnoor
    Estes, Chris
    Razavi, Homie
    Sherman, Morris
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 28 (05): : 243 - 250
  • [36] Interferon-lambda and therapy for chronic hepatitis C virus infection
    Donnelly, Raymond P.
    Dickensheets, Harold
    O'Brien, Thomas R.
    TRENDS IN IMMUNOLOGY, 2011, 32 (09) : 443 - 450
  • [37] Risk factors for the development of diabetes mellitus in chronic hepatitis C virus genotype 4 infection
    Chehadeh, Wassim
    Abdella, Nabila
    Ben-Nakhi, Abdullah
    Al-Arouj, Monira
    Al-Nakib, Widad
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (01) : 42 - 48
  • [38] The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C
    van Santen, Daniela K.
    Agius, Paul A.
    Sasadeusz, Joseph
    Fairley, Christopher K.
    Sievert, William
    Gane, Edward
    Iser, David
    O'Reilly, Mark
    Medland, Nicholas A.
    Moore, Richard
    Hellard, Margaret E.
    Hoy, Jennifer F.
    Doyle, Joseph S.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 85 (05) : E81 - E89
  • [39] Impact of Direct-Acting Antiviral Treatment on Glucose Metabolism in Patients with Chronic Hepatitis C Virus Infection
    Barreiro, Joana da Fraga
    Fernandes, Dalia
    Santos, Maria Joana
    REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2021, 16 (3-4) : 110 - 117
  • [40] Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection
    Sato, Masaya
    Kato, Naoya
    Tateishi, Ryosuke
    Muroyama, Ryosuke
    Kowatari, Norie
    Li, Wenwen
    Goto, Kaku
    Otsuka, Motoyuki
    Shiina, Shuichiro
    Yoshida, Haruhiko
    Omata, Masao
    Koike, Kazuhiko
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E137 - E144